COLUMBIA, S.C., Oct. 24 (UPI) -- Eli Lilly has agreed to pay South Carolina a record $45 million to settle a dispute over the marketing of the anti-psychotic drug Zyprexa, officials say.
INDIANAPOLIS, Oct. 21 (UPI) -- U.S. pharmaceutical Eli Lilly and Co. said it is close to settling federal and state probes into its marketing of the anti-psychotic medication Zyprexa.
ANCHORAGE, Alaska, March 26 (UPI) -- Eli Lilly and Co. will pay Alaska $15 million to settle claims it failed to disclose side effects of the drug Zyprexa, the two sides announced.
ANCHORAGE, Alaska, March 12 (UPI) -- A former U.S. drug regulator testified at a trial in Alaska Monday that Eli Lilly tried to minimize the negative aspects of the drug Zyprexa.
INDIANAPOLIS, June 12 (UPI) -- Indianapolis-based drug giant Eli Lilly and Co. said Tuesday it settled 900 more product liability claims against its top-selling drug Zyprexa.
WASHINGTON, April 25 (UPI) -- The U.S. Food and Drug Administration is reviewing documents provided by the maker of the antipsychotic drug Zyprexa.
INDIANAPOLIS, Jan. 4 (UPI) -- Eli Lilly said Thursday it entered into settlement agreements to resolve most of the U.S. liability lawsuits relating to its antipsychotic Zyprexa.
INDIANAPOLIS, Jan. 4 (UPI) -- Eli Lilly and 14 plaintiff attorneys agreed to settle in the liability litigation of Zyprexa, a pill used to treat schizophrenia and bipolar disorder.
NEW YORK, Dec. 16 (UPI) -- Internal company documents show that Eli Lilly concealed information about side effects of its schizophrenia drug Zyprexa, The New York Times said Saturday.
INDIANAPOLIS, June 10 (UPI) -- Eli Lilly & Co. of Indianapolis plans to pay up to $690 million to settle as many as 8,000 claims against its anti-psychotic drug Zyprexa.
